Welcome to Paratek Medical Affairs
This web portal is intended as an educational resource for healthcare professionals practicing in the U.S. Information provided is for informational purposes and is not intended to promote the use of any product. Please review the relevant package insert for safety information and directions for use before prescribing medications.
Are you a health professional practicing in the United States?

Welcome to Paratek
Medical Affairs

Welcome to Paratek
Medical Affairs

Welcome to Paratek
Medical Affairs

Microbiology

A Novel Plasmid-Borne tet(X6) Variant Co-existing with bla(NDM-1) and bla (OXA-58) in a Chicken Acinetobacter baumannii Isolate
Zheng
et al.
Journal of Antimicrobial Chemotherapy
Accepted, epub ahead of print
August 7, 2020
Antibiotic Susceptibility of NDM-Producing Enterobacterales Collected in the United States, 2017–2018
Lutgring
et al.
American Society for Microbiology Journals
64(9):e00499-20
August 20, 2020
In Vitro and Intracellular Activities of Omadacycline against Staphylococcus aureus Isolates
Jacques Dubois
et al.
Internal Med resOpen J
5(2):1-6
June 1, 2020
Repurposing Drugs for Treatment of Mycobacterium abscessus: A View to a Kill
Gumbo
et al.
Journal of Antimicrobial Chemotherapy
75(5):1212-1217
February 4, 2020
In Vitro Activity of Omadacycline against Pathogens Isolated from Mainland China during 2017–2018
Dong
et al.
European Journal of Clinical Microbiology & Infectious Diseases volume
39:1559-1572
April 30, 2020
In Vitro and Intracellular Activities of Omadacycline against Legionella pneumophila
Dubois
et al.
Antimicrob.Agents andChemother.
64(5):e01972-19
April 1, 2020
In vitro Activities of Omadacycline against Rapidly Growing Mycobacteria
Shoen
et al.
Antimicrob.Agents andChemother.
63:e02522-18
May 4, 2019
In Vitro Activity of Omadacycline against Chlamydia pneumoniae
Kohlhoff
et al.
Antimicrob.Agents andChemother.
63:e01907-18
February 5, 2019
Omadacycline: Comparative In vitro Activity against Dog and Cat Bite Wound Isolates
Goldstein
et al.
Antimicrob.Agents andChemother.
62:e02551-17
April 1, 2018
The In Vitro Activity of Omadacycline and Comparators Against Anaerobic Bacteria
Stapert
et al.
Antimicrob.Agents andChemother.
62:e00047-18
April 2, 2018
Activity of Omadacycline Tested against Streptococcus pneumoniae from a Global Surveillance Program (2014)
Pfaller
et al.
Diagnostic Micro.& Infect. Dis.
90(2):143-147
February 3, 2018
In Vitro Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria
Brown-Elliot
et al.
Antimicrob Agents and Chemother.
65(3):e01947-20.
February 17, 2021
Omadacycline compared to vancomycin when combined with germinants to disrupt the life cycle of Clostridioides difficile
Budi
et al.
Antimicrob Agents and Chemother.
Epub ahead of print. PMID: 33649111.
March 2, 2021
In Vitro Susceptibility of Rickettsia Species to Eravacycline, Omadacycline, and Tigecycline
Quade et al.
et al.
Antimicrob Agents and Chemother
65(8):e00665-21
July 16, 2021

Publication Categories

Contact Us

In light of the COVID-19 pandemic, you may experience a busy signal when calling our Paratek Call Center. Please continue to try your call throughout the day to report adverse events and product quality complaints or obtain medical information for our products.

MSD Contact Form
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By completing this form, I verify that I requested this information completely independently and solely for my own evaluation and application to my practice, patients, or general education, or for the pharmacy and therapeutics committee. I affirm that my request was in no way prompted by Paratek Pharmaceuticals or any representative of Paratek.

Medical Information
If you would like to speak to a Paratek Medical Information Professional please call Paratek Customer Service at 1-833-PARATEK (1-833-727-2835) (Monday to Friday, 8 AM to 8 PM ET, excluding holidays) or email medinfo@paratekpharma.com
Report a Product Complaint
To report a Product Quality Complaint for a Paratek product, please call 1-833-Paratek (1-833-727-2835).
Report an Adverse Event
To report an Adverse Event for a Paratek product, please fill out a form or call us 1-833-PARATEK (1-833-727-2835). You can also contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Request follow-up from a Medical Science Director
If you would like additional information about our products or would like to discuss research ideas, please contact our MSD team.